Mayne Pharma Group Limited (OTCMKTS:MAYNF – Free Report)’s share price rose 14.8% during trading on Monday . The stock traded as high as $2.95 and last traded at $2.95. Approximately 7,950 shares traded hands during mid-day trading, an increase of 325% from the average daily volume of 1,871 shares. The stock had previously closed at […]
Mithra Pharmaceuticals: Mithra has access to the new EUR 12.5 million tranche of the Highbridge/Whitebox loan facility finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Mithra has access to the new EUR 12.5 million tranche of the Highbridge/Whitebox loan facility Liege, Belgium, 21 June 2023 – 17:50 CEST – Mithra Pharmaceuticals SA (Euronext Brussels: MITRA) (the
Mithra has access to the new EUR 12.5 million tranche of the Highbridge/Whitebox loan facility itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.
Mithra has access to the new EUR 12.5 million tranche of the Highbridge/Whitebox loan facility itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.
Allied Market Research published a report, titled, “Acne Medication Market by Therapeutic Class (Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide, and Others), Formulation (Topical Medications and Oral Medications), Type (Prescription Medicines and Over-The-Counter Medicines), Acne Type (Non-Inflammatory Acn...
Mayne Pharma Group Limited (ASX:MYX – Get Rating) insider Patrick Blake bought 3,097 shares of the business’s stock in a transaction on Thursday, April 13th. The stock was purchased at an average cost of A$4.07 ($2.73) per share, with a total value of A$12,592.40 ($8,451.28). Mayne Pharma Group Stock Performance The company has a debt-to-equity […]
Mayne Pharma Group Limited (ASX:MYX – Get Rating) insider Ann Custin bought 9,075 shares of the stock in a transaction dated Monday, April 17th. The shares were bought at an average cost of A$4.06 ($2.72) per share, with a total value of A$36,844.50 ($24,727.85). Mayne Pharma Group Price Performance The company has a quick ratio […]
/PRNewswire/ -- The spasticity treatment market size is forecast to increase by USD 1.11 billion from 2021 to 2026, at a CAGR of 4.17%, according to the recent...